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Abstract
Rationale Propensity for drug dependence shows great
diversity that is related to intrinsic neurobiological factors.
This diversity is important both for the understanding of these
traits and for the development of therapies.
Objectives The goals of the study were (1) to define, using
ultrasonic vocalization characteristics, inter-individual dif-
ferences in rats’ propensity for sensitization to amphet-
amine, (2) to test whether possible resistance to this effect
could be overcome with repetitive treatment, and (3) to seek
useful predictors of the propensity.
Methods Rats were subject to tests meant to characterize
their anxiety, pain sensitivity, and responses to novelty and
natural rewards. Then they were subject to the so-called
two-injection protocol of sensitization (using amphetamine)
followed by 2 weeks of daily amphetamine treatment, 2-week
withdrawal, and final amphetamine challenge. The develop-
ment and outcome of sensitization were monitored by
measuring 50-kHz vocalization.
Results The two-injection protocol yielded three patterns of
changes in the frequency-modulated 50-kHz vocalization
response to amphetamine. These patterns persisted after
completion of the extended drug treatment. Rats with lower
sensitivity to pain or with longer latency of their vocaliza-
tion response to the first drug exposure showed an increased
propensity for ultrasonic vocalization sensitization.
Conclusion Vulnerability to sensitization of frequency-
modulated 50-kHz vocalization response of Sprague–Dawley
rats to amphetamine, which supposedly reflects rats’ propen-
sity for amphetamine dependence, shows large inter-
individual diversity. Resistance to this effect, which is evident
in a majority of the rats, cannot be overcome even with
prolonged intermittent drug treatment under the conditions
(novelty) that promote sensitization.
Keywords Amphetamine . Drug dependence .
Frequency-modulated ultrasonic vocalization .
Inter-individual differences . Predictive power . Reward .
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Introduction
Of the large number of humans who experiment with addic-
tive drugs, relatively few eventually become addicted
(Zuckerman 1984; Le Moal and Koob 2007). This subpop-
ulation also shows resistance to addiction therapy. The bases
of these peculiarities are not clear, but it is generally recognized
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that the emergence of drug addiction is related, among others,
to some pre-requisite, intrinsic biological factors. Such factors
likely involve genetic background and/or a dysfunction in
some neurotransmitter/neuromodulator system(s) (Bardo et
al. 1996; Johansson and Hansen 2001; Cain et al. 2005; Sinha
2008; Taracha et al. 2011). Diversity of these factors and their
combinations translates into heterogeneity with regard both to
the propensity for addictions and to the sensitivity to the
respective therapies. This heterogeneity is supported by both
human and animal studies (Zuckerman 1984; Kalinichev et al.
2004; Kabbaj 2004, 2006; Cain et al. 2005; Pelloux et al. 2006;
Everitt et al. 2008; Flagel et al. 2010).
The key attribute of addictive drugs is their ability for
stimulating brain reward system(s) and for long-lasting poten-
tiation (i.e., sensitization) of this effect. In laboratory rodents,
these effects were usually assessed indirectly, e.g., using con-
ditioned place preference or locomotor activity tests. Lately,
the options for detecting and assessing affective states in rats
and mice have been greatly enriched with methods based on
measuring ultrasonic vocalization (USV) that is a common
way of communication in these species (Knutson et al. 2002;
Brudzynski 2007, 2009; Wang et al. 2008; Burgdorf et al.
2011). Adult rats vocalize in two frequency bands that are
usually called 22 and 50 kHz, but actually range from 18 to
22 kHz and from ~30 to >100 kHz, respectively. The former
(termed aversive or alarm) supposedly reflects negative affec-
tive states, e.g., fear or perception of danger from a predator.
The higher frequency band calls, which can be highly modu-
lated, usually associate with positive affective states evoked
by naturally rewarding events (or anticipation of such), e.g., by
access to food, social contacts with conspecifics, sex, or fresh
bedding (Panksepp and Burgdorf 2000; Bialy et al. 2000;
Brudzynski and Pniak 2002; Wang et al. 2008; Natusch and
Schwarting 2010). They can also be induced by addictive
drugs, e.g., cocaine (Maier et al. 2010; Barker et al. 2010;
Ma et al. 2010) or amphetamine (Burgdorf et al. 2001b;
Thompson et al. 2006; Wang et al. 2008; Wright et al. 2010,
2012; Brudzynski et al. 2011), or by drug context (Burgdorf et
al. 2001a; Ma et al. 2010). Notably, 50-kHz USV requires
activation of the mesolimbic dopamine system (Wintink and
Brudzynski 2001; Thompson et al. 2006; Brudzynski 2009)
that plays a key role in the rewarding effect of these drugs.
Similarly to certain non-vocalizational behavioral responses,
appetitive USV can show sensitization after repeated exposure
to psychoactive drugs (Barker et al. 2010; Ahrens et al. 2009).
Moreover, like the propensity for addictions, 50-kHz vocaliza-
tion response to non-pharmacological stimuli shows major
inter-individual diversity, but little intra-individual variability
(Schwarting et al. 2007; Mällo et al. 2007), implying a sub-
stantial role of genetic milieu (Brunelli and Hofer 2007;
Burgdorf et al. 2009). These similarities may herald the
utility of 50-kHz vocalization characteristics as an index of
vulnerability to drug dependence.
This report presents an attempt to define individual dif-
ferences in rats’ propensity for USV sensitization to am-
phetamine. We assumed that this sensitization might be
achieved with the two-injection protocol of sensitization
(TIPS) that has been successfully used for locomotor sensi-
tization of mice to morphine and cocaine (Valjent et al.
2010). We were also curious whether possible resistance to
this effect could be overcome with repetitive exposure, and
we sought USVand perhaps other behavioral characteristics
that would help predict USV sensitization to amphetamine.
We hypothesized that there may be a link between USV
sensitization to the drug and reactivity both to novelty,
seeking of which is an established risk factor for drug
abuse/dependence (Piazza et al. 1989; Kabbaj 2006), and
to some naturally rewarding events, e.g., to post-isolation
contact with a cage-mate (Panksepp and Burgdorf 2000;
Brudzynski and Pniak 2002; Hamed et al. 2009). A vital
role in controlling various effects of amphetamine and its
active congeners plays the brain opioid system (Gianoulakis
2004; Burgdorf et al. 2009; Tien and Ho 2011), which is
well-known to be responsible for reactivity to pain; for a
review see Bodnar (2011). There is also considerable
evidence showing a variety of anxiety-related actions of
amphetamine (Dawson et al. 1995; Biala and Kruk 2007;
Biala et al. 2009; Kitanaka et al. 2008; Barr et al. 2010;
Ennaceur et al. 2010). Hence, we assumed that anxiety
and reactivity to pain might be other likely predictors of
USV sensitization to the drug.
Materials and methods
Animals
Twenty-two male Sprague–Dawley rats from the stock of
the Polish Academy of Sciences Mossakowski Medical
Research Centre, Warsaw, Poland were used for the study.
The rats were 6–7 weeks old on arrival (initial body weight
142–174 g) and were housed six or four per opaque plastic
cage (55×33 cm floor size) in a temperature- and humidity-
controlled room (21±2°C, 60–70% relative humidity) under
a 12-h light/12-h dark cycle (lights on at 7 a.m.). They had
ad libitum access to tap water and standard laboratory rodent
chow and weighed 293–348 g (mean ± SD: 308±13 g) at
the beginning of drug treatment. Before the study, the rats
were given ten “daily” (excepting weekends) sessions of
handling and habituation to the testing milieu. The sessions
included transferring the rats in their home cages to the
testing room, placing them singly in a cage identical to the
home cage, but with no bedding, and gently stroking them
when on the experimenter’s hands and in the cage (for about
1 min each). The cage was cleaned and wiped with ethanol
after each rat. During the first handling session, the rats were
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monitored for USV because we expected some aversive
vocalization to be provoked by the encounter with un-
known humans (Brudzynski 2009).
Drugs
D-Amphetamine sulfate (Sigma-Aldrich) was dissolved
(2 mg/ml) in sterile aqueous 0.9% NaCl solution and was
injected to the rats intraperitoneally at the dose of 2 mg/kg.
Experimental design
The scheme of the experimental design is shown in Fig. 1.
The sequence of the tests preceding the beginning of am-
phetamine treatment (for tests’ details, see next sections)
was arranged according to their estimated degree of inva-
siveness, beginning with the least invasive one, to minimize
possible confounding effect on the next tests. After each of
the tests, the rats were instantly returned to their home cages
in the housing room. On the first day of drug treatment, they
were brought to the testing room again, placed singly in
clean clear plastic cages (56×34 cm floor size) with no
bedding, tested for USV just prior to and after drug injection
(for 10 and 20 min, respectively), and then returned to their
home cages in the housing room for a 5-day break from
injections and testing. Next, the rats were given the drug
“daily” (except weekends, a total of ten doses) after trans-
ferring them (all cage-mates together, except on USV testing
days) to clean cages (as above) in the testing room. One
hour after each drug injection, the rats were returned to the
housing room, except that after the first and the tenth dose,
they were tested again for USVas above. During the 2-week
withdrawal that followed the tenth daily dose, the rats stayed
in the housing room. Then they were given the final am-
phetamine dose and tested for USV as usual. All the tests
and injections were done during the light phase of the rats’
daily cycle. The study was designed and performed in
accordance both with the European Union directive on the
protection of laboratory animals (86/609 EEC) and with the
current laws of Poland, and all animal use procedures were
approved by the Bioethical Committee of the Medical
University of Warsaw.
Testing
Locomotor activity response to novelty (LAnov)
The rats were brought in their home cages to the testing room,
placed singly in fresh opaque plastic cages (56×34 cm floor
size) with no bedding, and immediately tested for locomotor
activity (distance covered) for 15 min using a model YR-600
1/3 in. CCD 540 TVL camera (Sony, Japan) fixed to the room
ceiling and a PC equipped with the EthoVision® XT Video
Tracking System v. 7 (Noldus Information Technology B.V.,
Wageningen, The Netherlands).
Elevated plus maze (EPM) test
The EPM apparatus was made of wood and consisted of two
opposed open arms and two opposed walled arms (arm floor
sizes, 50×10 cm) and an open square (10×10 cm) in the
center. The maze was elevated 50 cm above the room floor,
was lit with a dim red light from a model Philips PF212E*1E
bulb fixed 1.7 m above the floor of the EPM apparatus, and
was monitored with the aforementioned video system. The
rats were transferred singly to the testing room, placed on the
central square, facing an open arm, and had 5min access to the
maze. Video recordings were then used to calculate the relative
time spent on the open arms (expressed as percentage of total
time spent in the apparatus).
Hot-plate (HP) test
To prevent rats associating the HP test-related, relatively
strong stress with the regular testing room, the test was
performed in a separate room, using a model HP-01
instrument (COTM, Białystok, Poland). Plate temperature
was kept at 56±0.1°C and the cut-off time was set at 30 s
to prevent tissue damage. Rats were brought singly to the
room and placed with all four paws on the plate, and the
Fig. 1 Scheme of experimental design
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latency time to licking or shaking a fore or hind paw was
measured.
USV recording
Excepting the USVpi test (see below), USV calls were
recorded using a single condenser microphone CM16/CMPA
(Avisoft Bioacoustics, Berlin, Germany) placed face down on
the wire cover of the cage. The microphone was sensitive to
frequencies of 15–180 kHz, had a flat response characteristic
(±6 dB) in the 25–140-kHz range, and was connected to a
custom-made amplifier of the following characteristics: fre-
quency response ±0.1 dB (0.3–100 kHz), input impedance
600Ω, and voltage gain 16 V/V (12 dB). The amplified signal
was sent to an adjacent (observer-occupied) room and passed
through a custom-made anti-aliasing filter. The filtered signal
was sent to a PC equipped with a model PCI-703-16A acqui-
sition board (14-bit, 400 kHz; Eagle Technology, WI, USA)
and custom-written software (Rat-Rec Pro 5.0), processed
using a fast Fourier transform (1024 or 512, Hamming or
Hann window) and displayed as a color spectrogram.
Frequency-modulated (FM) 50-kHz calls (“trills”) and non-
FM (“flat”) 50-kHz calls were identified using the character-
istics given in earlier reports of the relevant rat studies (Wöhr
et al. 2008; Ahrens et al. 2009;Wright et al. 2010). Each signal
was manually marked to be included in the automated param-
eter measurement that included the following characteristics:
number, mean and summary duration, frequency bandwidth
and mean peak frequency of FM 50-kHz calls, and number of
non-FM 50-kHz calls.
Post-isolation USV (USVpi) test
After a 24-h isolation (see the experimental design above),
the rats were brought (in pairs, each rat in his isolation cage)
to the testing room. The testing chamber consisted of the
respective home cage (with “old” bedding in place) that was
divided crosswise into two equal parts with a barrier com-
posed of two pieces of 6-mm-thick plywood separated with
a 3-cm-thick sheet of polyurethane foam. One of the ply-
wood pieces had two horizontal rows of ϕ06-mm holes
located 7.5 cm (eight holes) and 9.5 cm (six holes) from
the lower edge; the holes were drilled 2 cm apart (center to
center) and were located symmetrically in relation to the
cage width. All three barrier parts closely fitted the cage
cross-section, with the upper rim of each part protruding
20 cm above the cage rim and 10 cm sidewise on both sides.
During the test, each cage section was covered with a
separate wire cover. There was one ultrasound microphone
placed on each cover, facing down. USV recording was
performed for 10 min with all barrier parts in the “shut”
position, then the solid plywood piece and the foam sheet
were raised to level their lower edges with the cage rim, and
the recording was continued for another 10 min. The perfo-
rated plywood piece, which remained in the “down” posi-
tion to keep each rat in its assigned cage section, did not
prevent the microphones from occasional collecting USV
from the rat who stayed on the opposite side of the barrier;
however, the “bias” calls were easily discerned by their low
volume when comparing the respective “paired” sonograms.
Statistics
Data are expressed as the mean ± SEM except when specified
otherwise or shown individually. USV rate data (numbers of
FM 50-kHz calls/time unit) were analyzed by a two-way or
three-way ANOVA as needed, followed by post-hoc Tukey’s
test when appropriate, except that “anticipatory” USV rate
data, because of extreme deviation from normal distribution,
were analyzed using nonparametric tests (Friedman’s
ANOVA or Kruskal–Wallis ANOVA followed by the Dunn
test of multiple comparisons when appropriate). For the anal-
ysis of predictive power of the various tests utilized, the rats
were classified into low and high responders using “median
split”. In all cases, a p<0.05 was considered significant. All
statistical analyses were performed using the Statistica v. 7.1
software package (StatSoft Inc., Tulsa, OK, USA).
Results
Over the study period, rats showed no perturbation in their
weight gaining and no other signs that might have suggested
health problems. No 50-kHz call was detected during the
first handling/habituation session, whereas there were four
20-kHz calls, all from a single rat.
Preliminary two-way repeated measures ANOVA of FM
50-kHz response to amphetamine (expressed as the number of
calls per 2-min interval) for the entire rat cohort and all 4 days
of USV testing yielded significant effects of post-drug session
time (F9, 18908.15, p<0.001), day (F3, 6303.24, p00.028),
and day × post-drug session time interaction (F27, 56704.99,
p<0.001).
FM 50-kHz vocalization effects of TIPS
The first amphetamine dose evoked a continuous increase in
USV rate, with a tendency to plateau during the other half of
the session, whereas the second dose (day 7) resulted in
maximum USV rate at 8 min, followed by a slight decrease
with a tendency to plateau at the end of the session (see
Fig. 2). Repeated measures two-way ANOVA of the USV
response data for the entire study cohort for days 1 and 7
showed no sensitization. However, the difference in the time
course of the USV responses to the two drug doses, which
was evidenced by statistically significant day × post-drug
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session time interaction effect, has prompted us to take a
closer look at individual rat responses (not shown). Visual
inspection revealed three patterns of changes. Half (N011)
of the cohort studied showed a small increase in USV rate
beginning at about 6 min and plateauing in the second half
of the day 1 session. These rats showed poor response to the
second dose, and their mean day 7 FM 50-kHz rate was
below that found on day 1 (Fig. 3a); hence, they were
termed “negative responders” (negR). Six rats showed a
much larger increase in USV rate after the first drug dose,
which lasted until the end of the session. These rats showed
similar, but almost instant increase in USV rate after the
second dose, but this response began to wane about 6 min
post-drug and faded away before the session’s end (Fig. 3b);
hence, they were termed “low responders” (LR). The
remaining five rats showed moderate and much delayed
increases in USV rate after the first drug dose, but their
USV response to the next dose began noticeably earlier,
was much stronger, and lasted to the end of the session with
no sign of abating (Fig. 3c); we termed these rats “high
responders” (HR).
FM 50-kHz vocalization effects of repetitive amphetamine
treatment
We attempted to analyze USV rate response data across all
4 days of testing for each rat subset separately by a repeated
measures two-way ANOVA with treatment day and post-
drug session time as repeated measures factors. The analysis
using 2-min interval data was not feasible for the negR and
HR subsets, as the software used reported no variability of
the dependent variable; hence, the 2-min interval data were
merged into two 10-min “blocks”. The respective two-way
ANOVA re-analysis yielded significant effect of repetitive
drug treatment on USV time course in all three subsets
(day × post-drug session time interaction effect—negR rats:
F3, 3004.22, p00.013; LR rats: F1, 1505.20, p00.012; HR
rats: F3, 1204.05, p00.033). The treatment transiently (day 7)
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Fig. 2 FM 50-kHz calling response to amphetamine two-injection
protocol of sensitization in non-categorized study cohort. Two-way
ANOVA—day effect: F1, 2100.16, p00.70; post-drug session time
effect: F9, 18907.24, p<0.001; day × post-drug session time interaction
effect: F9, 18903.20, p00.001
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Fig. 3 Patterns of FM 50-kHz USV responses to amphetamine two-
injection protocol of sensitization. a Averaged response profiles of
negative responders (negR); b averaged response profiles of low res-
ponders (LR); c averaged response profiles of high responders (HR).
Please note that the averaged 2-min interval response profiles are
shown only for illustration and the ANOVA results shown refer to
10-min time “blocks”. Three-way ANOVA—group effect: F2, 1907.19,
p00.005; day effect: F1, 1904.16, p00.055; post-drug session time
effect: F1, 19015.23, p00.001; day × group interaction effect: F2, 190
14.22, p<0.001; group × post-drug session time interaction effect:F2, 190
4.94, p00.019; day × post-drug session time interaction effect: F2, 190
9.04, p00.007; day × post-drug session time×group interaction effect:
F2, 19012.31, p<0.001. *p<0.05, **p<0.01 vs. the corresponding
10-min block value for day 1; the Tukey test
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suppressed the USV rate response in negR rats (day effect:
F3, 3003.22, p00.037), did not significantly affect it in LR rats
(day effect: F3, 1500.48, p00.70), and markedly enhanced it
in HR rats (day effect: F3, 1204.85, p00.020). Notably, USV
rate response of the HR rats to the final drug dose (day 35) was
significantly stronger than that to the second dose, while no
similar change was found in the other rat subsets. For a detailed
analysis of within- and between-subset effects, see Fig. 4.
Median split categorization of the study rats based on the
rate of their FM 50-kHz calling response to the first drug
dose (see Fig. 5a) yielded no predictive value with regard to
sensitization of the FM 50-kHz response to amphetamine
(three-way ANOVA—category effect: F1, 2002.06, p00.17;
category × day interaction effect: F3, 6000.27, p00.85).
Repetitive amphetamine treatment resulted in marked
decreases in the latency time of the first post-drug FM
50-kHz call. This effect was most prominent in the HR rats
(Fig. 6).Median split categorization of the study cohort by this
latency (see Fig. 5b) showed that long latency was a significant
predictor of USV sensitization (see Fig. 7).
“Anticipatory” FM 50-kHz vocalization
Very few FM 50-kHz calls were found during the sessions
that preceded the first two amphetamine injections, but
continued drug treatment resulted in markedly increased
“anticipatory” FM 50-kHz calling (Fig. 8). This effect
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Post-amphetamine session time
Fig. 4 Effect of repetitive
amphetamine treatment on FM
50-kHz USV response profiles
in various rat subsets (negR
negative responders, LR low
responders, HR high
responders). The upper panels
are for illustration purpose only;
hence, error bars are not shown.
The ANOVA results given
below refer to the data shown in
the lower panels. Three-way
ANOVA—group effect:
F2, 19014.88, p<0.001; day
effect: F3, 5708.89, p<0.001;
post-drug session time effect:
F1, 1900.35, p00.56;
day × group interaction effect:
F6, 5706.24, p<0.001;
group × post-drug session time
effect: F2, 1900.90, p00.42;
day × post-drug session time
interaction effect: F3, 57011.90,
p<0.001; day × group × post-
drug session time interaction
effect: F6, 5703.59, p00.004.
*p<0.05, ***p<0.001 vs. the
respective day 1 10-min block
value; Δp<0.05,
ΔΔΔp<0.001 vs. the
respective day 7 10-min block
value; •p<0.05, •••p<0.001 vs.
the corresponding HR group
value; the Tukey test
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subset (Friedman’s ANOVA: χ2df03, N022022.1, p<0.001
and χ2df03, N05011.8, p00.008, respectively). There was
no significant between-group difference in the anticipatory
USV rate (p≥0.37, Kruskal–Wallis ANOVA) except before
the last drug dose when the HR rats produced significantly
more USVs than their negR counterparts (Fig. 8).
FM 50-kHz vocalization characteristics
Summary duration of FM 50-kHz calls in individual rats
(not shown) correlated highly (linear correlation coefficients
from 0.98 to 1.00) with FM 50-kHz calling rates for 10-min
recording session blocks on all testing days. Mean call
duration for the first 10-min block ranged from 35.6±
2.5 ms (day 1) to 42.4±1.1 ms (day 35) and that for the
other 10-min block ranged between 34.8±1.3 ms (day 1)
and 42.4±1.6 ms (day 7). Three-way ANOVA of mean call
duration data, with rat subset (negR, LR, and HR) as the
main factor, and testing day (days 1, 7, 20, and 35) and post-
drug session time (two 10-min blocks) as the repeated
measures factors yielded no significant effect of any factor
(p≥0.27) or factor interaction (p≥0.30). Mean frequency
bandwidth ranged from 12.6±1.2 kHz (day 1) to 19.1±
1.0 kHz (day 35) for the first 10-min block and from 14.2±
0.9 kHz (day 1) to 17.8±1.0 kHz (day 35) for the second
block. Repeated measures three-way ANOVA of the frequen-
cy bandwidth data also showed no significant effect of indi-
vidual factors (p≥0.12) or of factor interactions (p≥0.52).
Mean call frequency ranged from 64.0±1.9 kHz (day 1) to
65.2±1.4 kHz (day 7) for the first 10-min block and from
66.2±1.4 kHz (day 1) to 68.9±1.6 kHz (day 7) for the
other half of the sessions. The respective three-way ANOVA
ofmean FM 50-kHz call frequency data showed no significant
effect of any factor (p≥0.13) or factor interaction (p≥0.19)
as well.
Rat categorization by USVpi and non-USV testing
Median split categorization of the study rats into HP high
responders and low responders (with below-median and
above-median HP latency, respectively; Fig. 9a) showed
significant predictive value for the sensitization of the FM
50-kHz response to amphetamine (see Fig. 10). Analogous
categorization of this cohort into EPM high and low res-
ponders (low-anxiety and high-anxiety rats, respectively;
Fig. 9b) yielded no significant prognostic value, but there
was a significant increase in the rate of FM 50-kHz calling
response to amphetamine in the EPM high responders at the
end of drug treatment (see Fig. 11).
Median split categorizations based on results of the
LAnov (Fig. 9c) and USVpi test (Fig. 9d) also showed no
predictive value: LAnov three-way ANOVA—category ef-
fect: F1, 1900.03, p00.86; category × day interaction effect:
F3, 5700.43, p00.73; FM 50-kHz USVpi rate three-way
ANOVA—category effect: F1, 2000.18, p00.67; category ×
day interaction effect: F3, 6000.69, p00.56. A closer


























































Fig. 5 Median split categorization of the study cohort according to the
rate of FM 50-kHz vocalization response to the first amphetamine dose
(a) and the respective latency of the first post-amphetamine FM 50-
kHz call (b)





























Fig. 6 Effect of repetitive amphetamine treatment on the latency of the
first post-drug FM 50-kHz call in various rat subsets identified based
on their response to the TIPS protocol (negR negative responders, LR
low responders, HR high responders). Two-way ANOVA—group effect:
F2, 1901.28, p00.30; day effect: F3, 57011.31, p<0.001; day × group
interaction effect: F6, 5702.14, p00.062. *p<0.05, **p<0.01 vs. the
corresponding day 1 value; the Tukey test
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scrutiny of the FM 50-kHz rate has shown that it was
strongly biased by an interaction between the test-paired
rats. Despite large between-pair variability, seven of the
tested pairs showed a good match in the number of FM
50-kHz calls emitted by the test-paired rats (rat A/rat B
calls ratio—1.02–1.76, “B” being the rat who vocalized
less); a major disparity was found for two pairs (calls
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Fig. 7 Effect of repetitive
amphetamine treatment on FM
50-kHz USV rate response
profiles in rats categorized by
ranking in relation to the
median latency time for the first
post-drug USV recording
session (LRUSV latency rats with
above-median USV latency,
HRUSV latency rats with
below-median USV latency).
The upper panels are for
illustration purpose only; hence,
for clarity, error bars are not
shown. The ANOVA results
given below refer to the data
shown in the lower panels.
Three-way ANOVA—category
effect: F1, 2001.36, p00.26;
day effect: F3, 6003.83,
p00.014; post-drug session
time effect: F1, 2000.53,
p00.48; day × category
interaction effect: F3, 6002.84,
p00.045; category × post-drug
session time interaction effect:
F1, 2000.05, p00.82;
day × post-drug session time
interaction effect: F3, 6007.96,
p<0.001; day × post-drug
session time × category
interaction effect: F3, 6001.47,
p00.23. *p<0.05, ***p<0.001
vs. the corresponding day 1
10-min block value;
ΔΔΔp<0.001 vs. the
respective day 7 10-min block



































Fig. 8 Effect of repetitive
amphetamine treatment on FM
50-kHz USV rate during the
10-min sessions preceding drug
injections. Dotted lines denote
mean FM 50-kHz calling rates
for the entire study cohort.
*p<0.05; Kruskal–Wallis
ANOVA followed by the
Dunn test
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an intermediate discordance (calls ratios: 2.9 and 5.0).
The rate of non-FM 50-kHz calling during the USVpi
test was negligibly small compared to that of FM 50-kHz
calling, and there was no apparent relationship between these
rates for any rat subset identified (see Fig. 9d).
Discussion
Repeated administration of psychoactive drugs, especially in a
novel environment (Badiani and Robinson 2004; Paolone et
al. 2007), is well known to induce behavioral sensitization in
laboratory rodents. In rats, this effect can be detected by
testing either the locomotor activity (Robinson and Berridge
1993; Vezina and Queen 2000; Vanderschuren and Kalivas
2000; Taracha et al. 2008; Ahrens et al. 2009) or FM 50-kHz
vocalization (Ahrens et al. 2009). However, the relationship
between these measures is not yet clear; see Ahrens et al.
(2009) and Mu et al. (2009).
Sensitization is usually assessed after a few weeks with-
drawal from repeated psychoactive drug treatment. Yet even
single doses of such drugs can initiate locomotor sensitization
(Robinson et al. 1982; Jackson and Nutt 2001; Vanderschuren
et al. 2001), especially when they are given in a unique, drug-
specific context (Valjent et al. 2010). Using the TIPS protocol
in mice, this effect was found to emerge within just 7 days
following the priming cocaine dose and somewhat later after
morphine treatment of mice (Valjent et al. 2010). We have
used a similar protocol here, but the second amphetamine dose
meant to reveal FM 50-kHz USV response sensitization was
also the beginning of daily treatment intended both to over-
come a possible resistance to the sensitization and to allow us
comparing the effects of single and multiple exposures to
the drug.
Notably, the TIPS protocol revealed no USV sensitiza-
tion to amphetamine in unselected Sprague–Dawley rats.
However, based on the data from individual USV recording
sessions associated with this protocol, we have identified
three rat subsets (negR, LR, and HR) that greatly differed in
their propensity for USV-defined sensitization. During the
period covered by the TIPS protocol, these subsets showed
distinct changes in their respective patterns of FM 50-kHz
calling response to amphetamine. The patterns established
during this time showed no qualitative change over the
course of further drug treatment. True sensitization of the
USV response in the TIPS protocol emerged only in the HR
rats. Notably, only these rats showed clear enhancement of
this effect with continued treatment and withdrawal. In
contrast, the remaining over three fourths of the study rats
showed no sensitization and only minor changes in the
characteristics of their responses to amphetamine during
the continued treatment, revealing an amazing resistance to
multiple amphetamine exposures. These results are in line with
the evidence that a single dose of a psychoactive drug can be
sufficient for the induction and maturation of the neurobiolog-
ical changes needed for the expression of sensitized locomotor
























































































































Fig. 9 Median split
categorization of the study
cohort according to HP
response latency (a), EPM open
arms relative time (b),
locomotor response to novel
environment (c), and
post-isolation encounter FM
USV rate (d). Please note that
the dashed lines in d denote
individual rat pairs, whereas the
single-digit numbers at the
symbols denoting individual
rats show the number of
non-FM 50-kHz calls uttered by
the respective rats during the
encounter session
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phenotype. They are also compatible with the view that
potentiation of sensitized phenotype by continued drug expo-
sure may result from either a progress in these processes, or
from other phenomena (Valjent et al. 2010).
There were major changes in the rate of FM 50-kHz calling
over the courses of all recording sessions. Similar changes
after acute amphetamine treatment have been found in another
study employing similarly long sessions (Wright et al. 2010),
but could not be seen in the only other rat USV study on
repeated amphetamine treatment (Ahrens et al. 2009) because
of the short session time employed (5 min). It should be
stressed that using these short sessions, at least some of our
HR rats would have been categorized as low responders,
whereas our LR rats would appear roughly equivalent to the
rats that were reported to sensitize to the drug in the study of
Ahrens et al. and would have been deemed “high responders”.
It is recognized that the rate of USV responses to different
stimuli is related to some heritable factors and shows large
individual variability (Brunelli 2005; Mällo et al. 2007;
Burgdorf et al. 2009). One may ask if the differences we
observed were really related to the reaction to amphetamine
or rather to individual rats’ ability for USV. Our data suggest
that rats’ propensity for USV sensitization to the drug is not
related to the rate of their response to the stimuli that induce
appetitive USV, e.g., to post-isolation contact with a cage-
mate, but is defined by some neurobiological peculiarities that
underlie their sensitivity to amphetamine.
Humans who are pleased with the acute effects of the first
drug dose are supposedly more prone for voluntary intake of
the next doses and thus show a higher risk for developing
addictions (de Wit 1998; Gabbay et al. 2010). Alternatively,
the inclination to drug addiction may be related to a deficit
in the function of brain reward system(s) (Vetulani 2001;
Winstanley et al. 2010; Koob 2012). Such deficits may
render natural rewards insufficiently gratifying and generate
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Day 1 Day7 Day20 Day35 








Day 1 Day 7
Day 20 Day 35
Fig. 10 Effect of repetitive
amphetamine treatment on FM
50-kHz USV rate response
profiles in rat subsets defined
by ranking in relation to the
median HP response latency
(LRHP rats with above-median
HP response latency, HRHP rats
with below-median HP
response latency). The upper
panels are for illustration
purpose only; hence, for clarity,
error bars are not shown. The
ANOVA results given below
refer to the data shown in the
lower panels. Three-way
ANOVA—day effect:
F3, 6003.76, p00.015; category
effect: F1, 2004.76, p00.041;
post-drug session time effect:
F1, 2000.53, p00.47;
day × category interaction
effect: F3, 6002.44, p00.073;
category × post-drug session
time interaction effect:
F1, 2000.30, p00.59;
day × post-drug session time
interaction effect: F3, 6008.37,
p<0.001; day × post-drug
session time × category
interaction effect: F3, 6002.57,
p00.063. ***p<0.001 vs. the
corresponding day 1 10-min
block value; Δp<0.05,
ΔΔΔp<0.001 vs. the
corresponding day 7 10-min
block value; #p<0.05 vs. the
corresponding 0–10-min block
value; the Tukey test
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capable of “compensating” the deficits by acutely modify-
ing brain chemistry. Hence, it was interesting to see whether
rats’ vulnerability to USV sensitization is related to their
sensitivity to pharmacological and natural rewards. Catego-
rization based on the results of post-isolation USV test has
failed in this respect. This outcome was likely to be blamed
on pre-existing relationships between the test-paired rats, as
it has been shown by others that appetitive USV from a rat
can modify this behavior in conspecifics (Sadananda et al.
2008; Wöhr and Schwarting 2009).
The positive affective state (as evidenced by the emission
of appetitive USV) elicited by the first drug dose also did not
differentiate our rats with regard to their vulnerability to USV
sensitization. Yet the long latency time for the first post-
amphetamine FM 50-kHz call appeared a significant predictor
of drug-induced USV sensitization. It is not possible to
decisively state whether the latency is related to the perception
of amphetamine as pleasant. However, the lack of predictive
power of the categorizations based on the rate of USV re-
sponse to the first drug dose and to the post-isolation contact
with cage-mate suggests no link between amphetamine-
induced USV sensitization and sensitivity to rewards.
FM 50-kHz vocalization is also assumed useful for eval-
uation of the affective states associated with anticipation of
the next doses of addictive drugs (Ma et al. 2010); we have
also found increased context-related USV rate in Sprague–
Dawley rats repeatedly treated with morphine (Hamed et al.,
unpublished data from this laboratory). This postulation has
been confirmed by statistical significance of the increases in
anticipatory USV found after multi-dose treatment in both
the HR subset and the entire rat cohort in our study. The
remaining USV characteristics that have been examined in
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Post-drug session time, min
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ΔΔΔ
Fig. 11 Effect of repetitive
amphetamine treatment on FM
50-kHz USV rate response
profiles in rat subsets
categorized by rat ranking in
relation to the median value of
the EPM test (HREPM rats with
above-median relative time
spent on the open arms of the
EPM, LREPM rats with
below-median relative time
spent on the open arms of the
EPM). The upper panels are for
illustration purpose only; hence,
error bars are not shown. The
ANOVA results given below
refer to the data shown in the
lower panels. Three-way
ANOVA—category effect: F1,
2001.01, p00.33; day effect:
F3, 6003.38, p00.024;
post-drug session time effect:
F1, 2000.54, p00.47;
day × category interaction
effect: F3, 6000.16, p00.92;
day × post-drug session time
interaction effect: F3, 6008.45,
p<0.001; category × post-drug
session time interaction effect:
F1, 2000.45, p00.51;
day × post-drug session
time × category interaction
effect: F3, 6002.78, p00.049.
***p<0.001 vs. the
corresponding day 1 10-min
block value, ΔΔΔp<0.001 vs.
the corresponding day 7 10-min
block value; "#p<0.05 vs. the
corresponding 0-10-min block
value; the Tukey test
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this study (mean call duration, summary calls duration, call
frequency bandwidth, and mean peak frequency) showed
remarkable stability. This finding is in agreement with the
report of Wright et al. (2010). Notably, these USV features
did not also differ between the various rat subsets identified.
Our results regarding sensitization of FM 50-kHz vocal-
ization response to amphetamine are in general agreement
with the report of Ahrens et al. (2009) despite much lower
vocalization rate of our rats. Notably, our rats uttered also
almost no 22-kHz (i.e., aversive) calls and no 50-kHz calls
during the first handling/habituation session. This low calling
rate, which also appertains to the FM 50-kHz vocalization that
preceded the administration of consecutive drug doses
(“anticipatory” USV), cannot be explained by different drug
administration routes because there is a similar discrepancy
between our data and those obtained in studies on acute USV
effects of amphetamine (Wright et al. 2010, 2012). The reason
of the disparity could be the fact that unlike most researchers,
we carried out our experiments during the light phase of the
rats’ daily cycle, i.e., during the period of low activity; this
condition seems to be of great importance for behavioral
effects of addictive drugs (see also Taracha et al. 2011). This
supposition is supported by the fact that we have observed
much more intense FM 50-kHz vocalization in Sprague–
Dawley rats placed under dim red light during the light phase
of their daily cycle, either with no additional treatment or after
i.p. physiological saline injections (Hamed et al., unpublished
data from this laboratory). Another cause of the said differ-
ences might be the different rat strain used. However, the
relatively low rate of the “anticipatory” USV in our rats could
be related also to a stronger conditioning effect in the other
models (Maier et al. 2010; Ma et al. 2010).
The only non-USV-based characteristic that showed some
promise as a predictor of the propensity for USV sensitization
to amphetamine in this study was lower sensitivity to pain (as
assessed by the HP test). This finding may be related to the
fact that the brain opioid system, which plays a key role in
reaction to pain, is also involved in controlling USV (Tien and
Ho 2011) and some positive affective state-related effects of
amphetamine (Wang and McGinty 1995; Olive et al. 2001;
Wiskerke et al. 2011). However, the significance of the HP
latency-based categorization of the study rats did not translate
into a significant between-group difference in post-drug FM
50-kHz calling rate on any testing day (see Fig. 7). Hence, the
prognostic power of HP test asks for verification, preferably in
a larger cohort. Lack of prognostic value of the categorization
based on the results of EPM testing may look somewhat
surprising, as there is evidence suggesting that a lowered
anxiety in this test is related to the propensity for cocaine
dependence in rats (Bush and Vaccarino 2007). Lack of pre-
dictive power of the locomotor activity response to a novel
environment in our study is more understandable, as the
results of this test are highly dependent on the exact way it
is performed and show major divergence between different
studies (see Kabbaj 2006; Beckmann et al. 2011).
One might argue that the battery of pre-drug treatments
applied to the rats in this study could have significantly biased
the results of amphetamine treatment. However, since we took
measures to minimize the confounding potential of these
manipulations, and since all study rats were subjected to
identical sequence of experimental manipulations, we believe
that the non-pharmacological procedures had no considerable
effect on the identified USV sensitization-related differences.
Concluding remarks
We have found that the two-injection protocol of sensitization
does allow to reliably define rat’s propensity for USV sensi-
tization to amphetamine, provided the sensitization is assessed
with consideration of both the changes in FM 50-kHz calling
rate and the changes in the latency and duration of the USV
response. USV recording sessions used for the evaluation
should be of at least 20-min duration to avoid misjudgment.
We have also shown that rats’ pain sensitivity and the latency
of their FM 50-kHz vocalization response to the first drug
dose have some prognostic power in relation to USV sensiti-
zation, at least for that to amphetamine. The most important
results of this study are as follows: (1) the propensity of male
Sprague–Dawley rats for FM 50-kHz USV sensitization to
amphetamine is highly diversified, (2) rats showing this vul-
nerability account for but a minor subset of unselected males,
and (3) the resistance of the remaining male Sprague–Dawley
rats to this sensitization cannot be overcome even with repet-
itive drug treatment under the conditions that promote sensi-
tization. These findings ask for a reassessment in a larger
cohort, possibly using more detailed FM 50-kHz character-
istics and longer USV recording sessions, as the relatively
long-lasting high post-amphetamine FM 50-kHz vocalization
rate in sensitized rats suggests that such approachmight reveal
additional characteristics of their response. It would also be
interesting to see whether the timing of amphetamine
treatment in relation to the rats’ daily cycle has a major impact
on USV sensitization.
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